A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants

2019 ◽  
Author(s):  
Keyword(s):  
Crossover Study ◽  
Healthy Participants

The effect of itraconazole on the pharmacokinetics of lorlatinib: results of a phase I, open-label, crossover study in healthy participants

2019 ◽  
Vol 38 (1) ◽  
pp. 131-139 ◽  
Author(s):  
Maulik Patel ◽  
Joseph Chen ◽  
Stephanie McGrory ◽  
Melissa O’Gorman ◽  
Sunil Nepal ◽  
...  
Keyword(s):  
Phase I ◽  
Crossover Study ◽  
Open Label ◽  
Healthy Participants

scholarly journals Effects of typhoid vaccine on inflammation and sleep in healthy participants: a double-blind, placebo-controlled, crossover study

2016 ◽  
Vol 233 (18) ◽  
pp. 3429-3435 ◽  
Author(s):  
Ann L. Sharpley ◽  
Charlotte M. Cooper ◽  
Clare Williams ◽  
Beata R. Godlewska ◽  
Philip J. Cowen
Keyword(s):  
Crossover Study ◽  
Typhoid Vaccine ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Healthy Participants

The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants

2019 ◽  
Vol 37 (2) ◽  
pp. 745-758 ◽  
Author(s):  
Joseph Chen ◽  
Huiping Xu ◽  
Sylvester Pawlak ◽  
Leonard P. James ◽  
Gerson Peltz ◽  
...  
Keyword(s):  
Crossover Study ◽  
Open Label ◽  
Healthy Participants

1785-P: Drug-Induced Blockade of the Herg-Voltage-Gated Potassium Channel Decreases Glucose-Stimulated Insulin and GLP-1 Secretion in Healthy Participants: A Crossover Study

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1785-P
Author(s):  
CHRISTIAN R. JUHL ◽  
JOSEPHINE BURGDORF ◽  
CECILIE KNUDSEN ◽  
SIMON VEEDFALD ◽  
JENS J. HOLST ◽  
...  
Keyword(s):  
Potassium Channel ◽  
Crossover Study ◽  
Drug Induced ◽  
Voltage Gated ◽  
Healthy Participants
Sign in / Sign up

Export Citation Format

Share Document